ES445274A1 - Aminocyclitol antibiotics and processes therefor - Google Patents

Aminocyclitol antibiotics and processes therefor

Info

Publication number
ES445274A1
ES445274A1 ES445274A ES445274A ES445274A1 ES 445274 A1 ES445274 A1 ES 445274A1 ES 445274 A ES445274 A ES 445274A ES 445274 A ES445274 A ES 445274A ES 445274 A1 ES445274 A1 ES 445274A1
Authority
ES
Spain
Prior art keywords
formula
hydrogen
hydroxy
compound
aminocyclitol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES445274A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STIRLING DRUG Inc
Original Assignee
STIRLING DRUG Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/550,273 external-priority patent/US3972930A/en
Priority claimed from US05/615,593 external-priority patent/US3982996A/en
Application filed by STIRLING DRUG Inc filed Critical STIRLING DRUG Inc
Publication of ES445274A1 publication Critical patent/ES445274A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/487Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/497Saturated compounds containing a keto group being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process for preparing a compound having formula I (herein) wherein it represents hydrogen or lower alkyl; R3 and R8 represent hydrogen or one of R1 R3 and R8 represents an omega-aminoalpha-hydroxy-lower alkanoyl group having the formula H2NCH2 (CH2) nCHOHCO- where n is zero or one, the other of R1, R3 and R8 is hydrogen R2 represents hydrogen or hydroxy; R5 represents hydrogen, hydroxy or halogen except that when R2 is hydrogen, R5 is not hydroxy in the cis position with respect to the amino groups in positions 1 and 3; and R6 and R7 each represent hydrogen or methyl, an acid addition salt thereof, characterized by cultivating a nutrient medium containing carbohydrates, a source or source of assimilable nitrogen, essential salts and a corresponding added aminocyclitol or a corresponding cyclitol thereby defined below in the presence of an appropriate mutant microorganism as defined below, and isolating the product from the culture medium where it is used: a) an aminocyclitol of Formula XI (herein) wherein R1 and R3 represent hydrogens or together represent a single bond linking the two amino nitrogen atoms together and R2 and R5 have the above meanings in the presence of an incapable mimic microorganism to sinter the aminocyclitol itself but being able to incorporate the aminocyclitol or the compound of Formula I under the above conditions where a compound of Formula I is produced where R1, R3 and R8 each represent hydrogen and R2, R5, R6 and R7 have the indicated meanings; b) a cyclitol having Formula IIIa or IIIb (herein) wherein in any case R is hydrogen or acetyl; R3'is oxo or hydroxy; and R2'and R5' each is hydrogen, hydroxide, or OR, in the presence of a strain of a microorganism that is capable of biosynthesizing the cyclitol unit but is capable of incorporating cyclitol into the antibiotic molecule as an aminocyclitol unit in where a compound of Formula I is produced wherein R1, R3 and R8 each represent hydrogen and R2, R5, R6 and R7 have the indicated meanings; except that R5 does not include halogen; or c) an aminocyclitol having Formula IIa or IIb (herein) wherein in either case R2'and R5' are each hydrogen or hydroxy in formula IIa and hydroxy or benzylideneimino in formula IIb, and R1'is amino, lower alkylamino or hydroxy in the presence of Micromonospora purpurea CCTA 31, 164 where a compound of Formula I is produced where R3 and R8 each represent hydrogen; R2, R5, R6 and R7 have the indicated meanings and R3 represents hydrogen or lower alkyl, except that R5 does not include halogen; and if it is desired to produce a compound wherein one of R1, R3 and R8 represents an omega-amino-alpha-hydroxy-lower alkanoyl group, react the compound of Formula I obtained according to (a), (b) or (c) with an N-hydroxy-succinimide ester having Formula IV (herein) where n is zero or one and subject the benzyloxycarbonyl group in the resulting product to hydrogenolysis with hydrogen through a catalyst, and if it is desired to convert the free base obtained into an acid addition salt thereof. (Machine-translation by Google Translate, not legally binding)
ES445274A 1975-02-18 1976-02-18 Aminocyclitol antibiotics and processes therefor Expired ES445274A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/550,273 US3972930A (en) 1975-02-18 1975-02-18 Aminocyclitol antibiotics
US05/615,593 US3982996A (en) 1975-09-22 1975-09-22 Process for preparing aminocyclitol antibiotics

Publications (1)

Publication Number Publication Date
ES445274A1 true ES445274A1 (en) 1977-06-16

Family

ID=27069389

Family Applications (1)

Application Number Title Priority Date Filing Date
ES445274A Expired ES445274A1 (en) 1975-02-18 1976-02-18 Aminocyclitol antibiotics and processes therefor

Country Status (21)

Country Link
JP (1) JPS51108041A (en)
AR (3) AR221027A1 (en)
AU (1) AU503105B2 (en)
CA (1) CA1061731A (en)
CH (3) CH617964A5 (en)
DE (1) DE2606517A1 (en)
DK (1) DK143111C (en)
EG (1) EG12994A (en)
ES (1) ES445274A1 (en)
FI (1) FI56026C (en)
FR (1) FR2301265A1 (en)
GB (1) GB1529376A (en)
GR (1) GR60050B (en)
IE (1) IE42807B1 (en)
IL (1) IL49053A (en)
IN (2) IN147046B (en)
NL (1) NL7601655A (en)
NO (3) NO147308C (en)
NZ (1) NZ180036A (en)
PT (1) PT64816B (en)
SE (2) SE7601810L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR955564A (en) * 1946-10-24 1950-01-17
AU2007255856B2 (en) 2006-06-02 2012-08-16 Meiji Seika Pharma Co., Ltd. Novel aminoglycoside antibiotic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606434A5 (en) * 1973-08-06 1978-10-31 Scherico Ltd

Also Published As

Publication number Publication date
EG12994A (en) 1980-07-31
CH618214A5 (en) 1980-07-15
AR227266A1 (en) 1982-10-15
NO147308C (en) 1983-03-16
DE2606517A1 (en) 1976-08-26
AU503105B2 (en) 1979-08-23
JPS51108041A (en) 1976-09-25
CA1061731A (en) 1979-09-04
FI760387A (en) 1976-08-19
DK143111C (en) 1981-11-16
NO146811B (en) 1982-09-06
PT64816A (en) 1976-03-01
FI56026B (en) 1979-07-31
IE42807L (en) 1976-08-18
PT64816B (en) 1978-07-03
NO803185L (en) 1976-08-19
NO148298B (en) 1983-06-06
AR217417A1 (en) 1980-03-31
DK143111B (en) 1981-03-30
IE42807B1 (en) 1980-10-22
DK63176A (en) 1976-08-19
AR221027A1 (en) 1980-12-30
IN149240B (en) 1981-10-10
SE7601810L (en) 1976-08-19
NO760472L (en) 1976-08-19
NZ180036A (en) 1979-10-25
NO146811C (en) 1982-12-15
IL49053A (en) 1979-11-30
IN147046B (en) 1979-10-27
CH618215A5 (en) 1980-07-15
NO820574L (en) 1976-08-19
FR2301265B1 (en) 1979-05-25
SE8007540L (en) 1980-10-27
FR2301265A1 (en) 1976-09-17
GB1529376A (en) 1978-10-18
GR60050B (en) 1978-04-04
NO148298C (en) 1983-09-14
FI56026C (en) 1979-11-12
AU1117776A (en) 1977-08-25
IL49053A0 (en) 1976-04-30
NO147308B (en) 1982-12-06
CH617964A5 (en) 1980-06-30
NL7601655A (en) 1976-08-20

Similar Documents

Publication Publication Date Title
CA2083041A1 (en) Labeled compounds for use in a diagnostic breath test
DE3062752D1 (en) Antibiotic c-15003 pnd-0 and production of antibiotic c-15003 pnd
GB1453425A (en) 2-oxo-tetrahydropyran derivatives and fermentative process for producing the same
ES442920A1 (en) Antibiotics
GB1491266A (en) Anti-tumor antibiotics aclacinomycins a and b
PH20534A (en) Novel cephalosporins having a mono or d-oxo-piperazino-carbonyl groups in the molecule and a pharmaceutical composition thereof
HK77293A (en) Antibiotic/antitumor compounds and their production
GB1426908A (en) 1-n--s--alpha-hydroxy-omega-aminoacyl- derivative of amino glycosidic antibiotics
ES445274A1 (en) Aminocyclitol antibiotics and processes therefor
ES376555A1 (en) Novel process for producing antibiotics bleomycin
GB1313149A (en) Antibiotic and preparation thereof
ES439464A1 (en) Process for the preparation of moenomycin
SE8007539L (en) aminocyclitols
GB1355734A (en) Process for producing antibiotic material
ES395935A1 (en) Antibiotic
ES480405A1 (en) Novel macrolide antibiotics and preparation thereof
GB1481529A (en) Cephalosporin antibiotic substance and the production thereof
ES382658A1 (en) Antibiotic and process for preparing same
ES2080068T3 (en) DERIVATIVES OF 2-PYRANONE AND ITS PREPARATION PROCEDURE.
GB1377715A (en) Polycyclic lactones and their preparation
GB1525977A (en) Aminoglycoside antibiotic complex
GB1165060A (en) New N,N-Diglycidyl-Bis-Hydantoinyl Methane Derivatives, Process for their Production, and Use
EP0139457A3 (en) An antibiotic compound and its production
ES456743A1 (en) Aminoglycoside antibiotic compounds and process for preparing the same
KR860002574A (en) Method for preparing the antibiotic AT 2433 complex